LONDON, May 16, 2023
/PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global
medical technology company, today introduces two key products that
close the feedback loop for its robotics and digital surgery
portfolio – Personalized Planning powered by AI and RI.INSIGHTS
Data Visualization Platform.
These solutions transform data into contextual intelligence by
enabling surgeons to see how pre-operative surgical plans and
intra-operative decision-making link to post-operative
outcomes.
RI.KNEE ROBOTICS™ v2.0 – Personalized Planning powered
by AI
Smith+Nephew's CORI™ Surgical System expands its
capability in knee replacement with Personalized Planning powered
by AI, guided by RI.INSIGHTS data. This new addition enables the
surgeon to set the initial implant placement within the total knee
arthroplasty procedure based on AI-guided reference values and the
surgeon's planning preferences for specific implants and
patient-specific deformities.
"Advanced analytics combined with the CORI Surgical System will
offer a new dimension in joint arthroplasty. It will allow for true
personalization when performing joint replacement procedures," said
Dr. Thorsten Seyler of Duke University.
This AI-powered enhancement enables surgeons to customize
planning to both their preferences and the patient's anatomy at the
time of surgery.
RI.INSIGHTS Data Visualization Platform
Through the
RI.INSIGHTS Data Visualization Platform, surgeons can reference
individual case performance and benchmark that data against an
anonymised global database. The platform was designed to give
surgeons a simple and effective way to link patient reported
outcome measures (PROMs) to pre-operative planning and
intra-operative decisions in robotically-enabled knee replacements.
Surgeon-specific dashboards provide the ability to analyze
procedure data, such as case times, resections and alignment, and
ligament tensioning data from the CORI Digital Tensioner.
RI.INSIGHTS delivers an elegant solution to visualize data, connect
PROMs, address known challenges with information access and
utilization, and transform surgical insights into actionable
information.
"The ability to retrospectively and prospectively evaluate and
characterize data, to do what is best for every patient is unique
and something we have not been able to do before now," said Dr.
Steven Nishiyama at Desert
Orthopaedic Center.
Smith+Nephew's robotics and digital surgery portfolio closes the
feedback loop between intra-operative decision-making and
post-operative evaluations as part of an on-going AI-initiative and
continued investment in software and data solutions.
To learn more about the latest advancements in orthopaedic
reconstruction and discover more about robotics and computer-guided
solutions, please go to www.smith-nephew.com.
About Smith+Nephew
Smith+Nephew is a portfolio medical
technology company focused on the repair, regeneration and
replacement of soft and hard tissue. We exist to restore people's
bodies and their self-belief by using technology to take the limits
off living. We call this purpose 'Life Unlimited'. Our 19,000
employees deliver this mission every day, making a difference to
patients' lives through the excellence of our product
portfolio, and the invention and application of new technologies
across our three global franchises of Orthopaedics, Sports
Medicine & ENT and Advanced Wound Management.
Founded in Hull, UK, in 1856,
we now operate in more than 100 countries, and generated annual
sales of $5.2 billion in 2022.
Smith+Nephew is a constituent of the FTSE100 (LSE:SN, NYSE:SNN).
The terms 'Group' and 'Smith+Nephew' are used to refer to Smith
& Nephew plc and its consolidated subsidiaries, unless the
context requires otherwise.
For more information about Smith+Nephew, please
visit www.smith-nephew.com and follow us
on Twitter, LinkedIn, Instagram or Facebook.
Forward-looking Statements
This document may
contain forward-looking statements that may or may not prove
accurate. For example, statements regarding expected revenue growth
and trading margins, market trends and our product pipeline are
forward-looking statements. Phrases such as "aim", "plan",
"intend", "anticipate", "well-placed", "believe", "estimate",
"expect", "target", "consider" and similar expressions are
generally intended to identify forward-looking statements.
Forward-looking statements involve known and unknown risks,
uncertainties and other important factors that could cause actual
results to differ materially from what is expressed or implied by
the statements. For Smith+Nephew, these factors include: risks
related to the impact of Covid, such as the depth and longevity of
its impact, government actions and other restrictive measures taken
in response, material delays and cancellations of elective
procedures, reduced procedure capacity at medical facilities,
restricted access for sales representatives to medical facilities,
or our ability to execute business continuity plans as a result of
Covid; economic and financial conditions in the markets we serve,
especially those affecting healthcare providers, payers and
customers (including, without limitation, as a result of Covid);
price levels for established and innovative medical devices;
developments in medical technology; regulatory approvals,
reimbursement decisions or other government actions; product
defects or recalls or other problems with quality management
systems or failure to comply with related regulations; litigation
relating to patent or other claims; legal and financial compliance
risks and related investigative, remedial or enforcement actions;
disruption to our supply chain or operations or those of our
suppliers (including, without limitation, as a result of Covid);
competition for qualified personnel; strategic actions, including
acquisitions and dispositions, our success in performing due
diligence, valuing and integrating acquired businesses; disruption
that may result from transactions or other changes we make in our
business plans or organisation to adapt to market developments;
relationships with healthcare professionals; reliance on
information technology and cybersecurity; disruptions due to
natural disasters, weather and climate change related events;
changes in customer and other stakeholder sustainability
expectations; changes in taxation regulations; effects of foreign
exchange volatility; and numerous other matters that affect us or
our markets, including those of a political, economic, business,
competitive or reputational nature. Please refer to the documents
that Smith+Nephew has filed with the U.S. Securities and Exchange
Commission under the U.S. Securities Exchange Act of 1934, as
amended, including Smith+Nephew's most recent annual report on Form
20-F, which is available on the SEC's website at www. sec.gov, for
a discussion of certain of these factors. Any forward-looking
statement is based on information available to Smith+Nephew as of
the date of the statement. All written or oral forward-looking
statements attributable to Smith+Nephew are qualified by this
caution. Smith+Nephew does not undertake any obligation to update
or revise any forward-looking statement to reflect any change in
circumstances or in Smith+Nephew's expectations.
™ Trademark of Smith+Nephew. Certain marks registered in US
Patent and Trademark Office.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/smithnephew-helps-personalize-robotically-enabled-surgery-with-ai-powered-planning-software-and-data-visualization-platform-301825239.html
SOURCE Smith & Nephew plc